Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: Message from Dr. Moro

Generic_profile
Rank: [?]
Mail Room
Points: [?]
164
Rating: [?]
Votes: 0
  • Currently 0.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Message from Dr. Moro

posted on Jun 11, 09 05:57AM

Please be advised that Dr. Moro wanted to make the following points known to everyone on this discussion forum. They have not been edited by AGORACOM. Here is what Dr. Moro had to say:

1) We have progressed significantly in the past few weeks toward obtaining further financing and we shall make the corresponding announcements once we have a concrete deal. The depressed share price has helped the process and we have heard comments in support of that concept from members of some of the financing groups we are working with.

2) The company's note holders are aware of our efforts and they are participating in some of the discussions related to financing.

3) Inverness continues its work on RECAF as anticipated.

4) Our lab and office continues to operate as it has in the past few months.

5) The collaboration with Goshen continues and we are in the process of increasing the number of samples previously studied.

6) We have significantly advanced in our effort to generate revenue in the near future aside from China. We'll be more explicit on this topic at a later date.

7) Given our current cash position, our BioCurex China initiative is delayed for the time being. BioCurex China will be set in high gear immediately after we secure financing.

8) Many of the questions we receive and comments we read are the result of a personal perception on how things work, or should work. Unfortunately in some cases the world does not work the way it should. For example, a YouTube video (which requires cash and/or time) will not result in the FDA fast tracking anything.

9) Some of our shareholders have supported us with private placements, which we greately appreciate. They have been instrumental in keeping us going at this diffult time. We expect they will be rewarded if and when things start moving back to normal. Investors interested in making a private placement can contact us at (604) 207 9150.

When I say that I cannot answer questions I expect your understanding and your trust. It is either because (a) there is nothing to say, (b) I find it inconvenient to release information or (c) I am using my time in a way that I think is more productive for you. On this subject, while I reserve the right to decide which questions I will answer and which one I won't, my silence should never be interpreted as an attempt to hide bad information.

We are currently concentrating in the big picture, namely financing and generating revenue; we'll take the time to address the smaller issues later on. I appreciate your pacience and your support and I am doing everything I can to reward them.

Dr. Ricardo Moro.

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM Twitter. Follow our small but powerful market tips .. Follow and Prosper

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote